Day surgery for nodular adenomyosis by microwave endometrial ablation in office-based gynecology

Akira Tsuda
In: Journal of Microwave Surgery · 2014 · vol. 32(1) , pp. 1–5 · doi:10.3380/jmicrowavesurg.32.1 · W2332346696
article OA: diamond CC0
🔓 Open OA copy Full text JSON View on OpenAlex View at publisher
⚙ AI-generated summary by qwen3.7-flash, 2026-09-03 ⓘ

Microwave endometrial ablation via transcervical microwave adenomyolysis effectively reduced menorrhagia and dysmenorrhea in twelve women with nodular adenomyosis during an office-based day surgery procedure.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by qwen3.7-flash, 2026-09-03 · read from full text ⓘ

This study evaluated the safety and effectiveness of microwave endometrial ablation using transcervical microwave adenomyolysis for treating nodular adenomyosis in an office-based setting. Twelve outpatients, averaging 46.5 years old, underwent the procedure to address menorrhagia and dysmenorrhea while avoiding hysterectomy. The results demonstrated a significant reduction in menstrual blood loss and pain scores, with high patient satisfaction levels reported after the short-duration surgery. This paper is centrally about adenomyosis — specifically evaluating a minimally invasive office-based surgical technique for managing nodular adenomyosis symptoms.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

【Objectives】The aim of the study is to evaluate the safety and effectiveness of microwave endometrial ablation (MEA) in women with nodular adenomyosis for office-based gynecology. 【Methods】Twelve outpatients (average age:46.5) who hoped to avoid hysterectomy underwent MEA with transcervical microwave adenomyolysis (TCMAM) for the treatment of menorrhagia due to nodular adenomyosis whose maximum diameter was 53.4±11.3mm. 【Results】The mean operation time was 20.1±4.9 min. The blood loss during a monthly menstrual period decreased to 1.4 (0~5) on VAS score (score before operation =10). The VAS score of dysmenorrhea decreased to 1.1 (0~4) . The average VAS score regarding feelings of satisfaction for MEA was 9.7(full score =10). 【Conclusion】MEA with TCMAM is feasible for treatment of both menorrhagia and dysmenorrhea due to nodular adenomyosis in office day surgical procedure.
Full text 1,962 characters · extracted from oa-doi-fallback · 2 sections · click to expand

Keywords

microwave endometrial ablation(MEA), nodular adenomyosis, transcervical microwave adnomyolysis(TCMAM), office gynecology 2014 Volume 32 Issue 1 Pages 1-5 Details

Abstract

【Objectives】The aim of the study is to evaluate the safety and effectiveness of microwave endometrial ablation (MEA) in women with nodular adenomyosis for office-based gynecology. 【Methods】Twelve outpatients (average age:46.5) who hoped to avoid hysterectomy underwent MEA with transcervical microwave adenomyolysis (TCMAM) for the treatment of menorrhagia due to nodular adenomyosis whose maximum diameter was 53.4±11.3mm. 【Results】The mean operation time was 20.1±4.9 min. The blood loss during a monthly menstrual period decreased to 1.4 (0~5) on VAS score (score before operation =10). The VAS score of dysmenorrhea decreased to 1.1 (0~4) . The average VAS score regarding feelings of satisfaction for MEA was 9.7(full score =10). 【Conclusion】MEA with TCMAM is feasible for treatment of both menorrhagia and dysmenorrhea due to nodular adenomyosis in office day surgical procedure. 【Methods】Twelve outpatients (average age:46.5) who hoped to avoid hysterectomy underwent MEA with transcervical microwave adenomyolysis (TCMAM) for the treatment of menorrhagia due to nodular adenomyosis whose maximum diameter was 53.4±11.3mm. 【Results】The mean operation time was 20.1±4.9 min. The blood loss during a monthly menstrual period decreased to 1.4 (0~5) on VAS score (score before operation =10). The VAS score of dysmenorrhea decreased to 1.1 (0~4) . The average VAS score regarding feelings of satisfaction for MEA was 9.7(full score =10). 【Conclusion】MEA with TCMAM is feasible for treatment of both menorrhagia and dysmenorrhea due to nodular adenomyosis in office day surgical procedure. © 2014 Study Group of Microwave Surgery Favorites & Alerts Recently viewed articles

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Outcome instruments

VAS-pain

Condition tags

adenomyosisdysmenorrhea

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (2)

References (6)

Source provenance

openalex
last seen: 2026-06-04T00:00:01.174412+00:00
License: CC0 · commercial use OK